Medicare Enrolled
Dr. Douglas Swartz, MD
Urology Physician · Jacksonville, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Swartz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Swartz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Swartz
Dr. Douglas Swartz is an urology physician in Jacksonville, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Swartz performed 11,297 Medicare services across 2,418 unique beneficiaries.
Between the years covered by Open Payments, Dr. Swartz received a total of $140,629 from 38 pharmaceutical and/or device companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Swartz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in FL
$140,629 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 46606 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗11,297
Medicare services
Top 10% in FL for urology physician
2,418
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~595 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 4,560 | $19 | $75 |
| BCG treatment for bladder cancer | 2,550 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,304 | $92 | $406 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,111 | $2 | $15 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 365 | $132 | $587 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
192 | $63 | $224 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
155 | $100 | $426 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
152 | $25 | $100 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
145 | $7 | $60 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
112 | $63 | $287 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
95 | $8 | $10 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
95 | $175 | $739 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
75 | $39 | $119 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
62 | $75 | $355 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
52 | $11 | $44 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
51 | $68 | $282 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
29 | $43 | $200 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
28 | $75 | $350 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
26 | $247 | $1,152 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $131 | $530 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
17 | $22 | $92 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
17 | $135 | $611 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
17 | $19 | $237 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
17 | $98 | $430 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
16 | $138 | $2,547 |
| Prostate tissue destruction using radiofrequency heated water vapor A procedure that destroys prostate tissue by using radiofrequency energy to heat water vapor. This method is applied to treat the prostate gland. |
13 | $244 | $5,731 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $569 | $2,829 |
| Prostate needle biopsy with image guidance A procedure to remove small tissue samples from the prostate gland using a needle. Image guidance is used to help the doctor accurately locate the area for sampling. |
11 | $298 | $1,208 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$140,629
Total received (2018-2024)
Avg $20,090/year across 7 years
Top 2% in FL for urology physician
38
Companies
134
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$135,880 (96.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,370 (3.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$378 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$18,833
2023
$18,365
2022
$18,657
2021
$19,445
2020
$18,196
2019
$19,815
2018
$27,318
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SRS Medical Systems, Inc.
$132,000
NxThera, Inc.
$2,796
Blue Earth Diagnostics Limited
$1,127
KARL STORZ Endoscopy-America
$990
Boston Scientific Corporation
$612
Medtronic USA, Inc.
$594
PFIZER INC.
$325
Dendreon Pharmaceuticals LLC
$240
Astellas Pharma US Inc
$211
Merck Sharp & Dohme Corporation
$202
Bayer HealthCare Pharmaceuticals Inc.
$184
PROGENICS PHARMACEUTICALS, INC.
$179
Janssen Biotech, Inc.
$160
BOSTON SCIENTIFIC CORPORATION
$122
Telix Pharmaceuticals
$108
Antares Pharma, Inc.
$98
TOLMAR Pharmaceuticals, Inc.
$84
Merck Sharp & Dohme LLC
$63
Novartis Pharmaceuticals Corporation
$57
UroGen Pharma, Inc.
$55
AngioDynamics, Inc.
$52
Rochester Medical Corporation
$47
Alnylam Pharmaceuticals Inc.
$46
UROGEN PHARMA, INC.
$45
Olympus America Inc.
$30
Allergan, Inc.
$23
BIOTISSUE HOLDINGS, INC.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
Laborie Medical Technologies Corp.
$22
Tolmar, Inc.
$21
Coloplast Corp
$16
AbbVie Inc.
$16
Teleflex LLC
$15
Agiliti Surgical, Inc.
$15
Aytu Bioscience, Inc
$13
Myovant Sciences Inc.
$12
Aroa Biosurgery Incorporated
$8
Retrophin, Inc.
$1
Top 3 companies account for 96.7% of total payments
Associated products mentioned in payments ›
(815) Thiola · 15FRX37CM · 3.5MM X 300CM. LGTH 9.8 FT · AUTOCLAV · Axumin · BOTOX · CHNL:7FR · CT3000 Pro Base Unit · ELIGARD · ERLEADA · EndoSheath Technology · FLEXIBLE CYSTOSCOPE · GENERAL BPH · GREENLIGHT · HOPKINS II · ILLUCCIX · INTERSTIM · INTERSTIM ICON · JELMYTO · KEYTRUDA · LIGHT CABLE · LUPRON DEPOT · LYNPARZA · Lasers · Lumenis Pulse 120H · MYRBETRIQ · Moses 550 DFL · NANOKNIFE · NEOX · NOCDURNA · Natesto · Nubeqa · ORGOVYX · OXLUMO · Otrexup · PLUVICTO · POSLUMA · PROVENGE · PYLARIFY · REZUM · RYBREVANT · Rezum · Spanner Prothetic Stent · TELESCOPE · TITAN · TRIA · UroCuff · UroLift System · VESICARE · XTANDI · XYOSTED · Xofigo · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (97%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for urology physician in FL.
Equivalent to $1,245 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
75
Per 100K population
7.4
County median income
$68,447
Nearest hospital
ASCENSION ST VINCENT'S RIVERSIDE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Swartz is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), with consulting-driven industry engagement in the top 2% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Swartz experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Swartz performed 4,560 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Swartz receive payments from pharmaceutical companies?
Yes. Dr. Swartz received a total of $140,629 from 38 companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Swartz's costs compare to other urology physicians in Jacksonville?
Dr. Swartz's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Swartz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Jacksonville
Browse urology physicians in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
SRS Medical Systems, Inc. Payments to Doctors
See all physicians who received payments from SRS Medical Systems, Inc.
By company
NxThera, Inc. Payments to Doctors
See all physicians who received payments from NxThera, Inc.
By company
Blue Earth Diagnostics Limited Payments to Doctors
See all physicians who received payments from Blue Earth Diagnostics Limited.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology